DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

6.32 -0.38 (-5.67%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACHN $6.32 -5.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.61
Previous Close $6.70
Daily Range $6.24 - $6.71
52-Week Range $6.04 - $12.94
Market Cap $863.0M
P/E Ratio -17.18
Dividend (Yield) $0.00 (0.0%)
Volume 2,560,942
Average Daily Volume 1,859,144
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drug Makers

ACHILLION PHARMACEUTICALS, INC. (ACHN) Description

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website: http://www.achillion.com/

News & Commentary Rss Feed

Why Achillion Pharmaceuticals Shares Crashed 37% in January

Investors continue to sell off the once-promising developer of hepatitis C drugs.

Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global Ea

Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global Eagle Entertainment, LendingClub and Barracuda Networks

A Company's First Profit Can Mean Big Profits to Investors

Achillion Pharmaceuticals (ACHN) Weak On High Volume

First Week of ACHN September 16th Options Trading

The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceu

The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceuticals and Inovio Pharmaceuticals

Achillion Pharmaceuticals is Now Oversold (ACHN)

Commit To Purchase Achillion Pharmaceuticals At $5, Earn 12% Using Options

Bristol-Myers (BMY) Collaborates with Dual Therapeutics

Achillion Pharmaceuticals (ACHN) Flagged As Strong On High Volume

See More ACHN News...

ACHN's Top Competitors

ACHN $6.32 (-5.67%)
Current stock: ACHN
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
BIIB $263.86 (-3.44%)
Current stock: BIIB